Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of TBN for injection plus thrombolysis in acute ischemic stroke
CTR20234018Phase 3Active
- Sponsor
- Guangzhou Magpie Pharmaceutical
- Start
- Oct 2025
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tetramethylpyrazine nitrone in ischemic stroke, sponsored by Guangzhou Magpie Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20234018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234018.